Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Hofer

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Revue Medicale Suisse|March 5, 2016
[Why do we need molecular medicine in oncology]Silvia Hofer
Praxis|April 13, 2017
Silvia Hofer
Targeted Oncology|September 10, 2010
Targeted therapies on the horizon for malignant gliomaSilvia Hofer, Roger Stupp
Journal of Neuro-Oncology|September 30, 2006
Gefitinib concentrations in human glioblastoma tissueSilvia Hofer, Karl Frei
European Journal of Cancer (Oxford, England : 1990)|October 2, 2018
Letter comments on EJC published article: Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2-positive breast carcinomatous meningitisSilvia Hofer, Stefan Aebi
European Journal of Pharmacology|April 3, 2013
Treatment of breast cancer brain metastasesSilvia Hofer, Bernhard C Pestalozzi
Targeted Oncology|September 3, 2010
Molecular markers in gliomas: impact for the clinicianSilvia Hofer, Andrew B Lassman
Praxis|December 13, 2017
Désirée Gassmann, Sandra Schmid, Silvia Hofer
Acta Oncologica (Stockholm, Sweden)|December 25, 2008
Evolution of glioblastomaSilvia Hofer, Spyros Kollias, Michael Weller
BMC Medical Informatics and Decision Making|July 23, 2013
Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluationDominik Péus, Nicolas Newcomb, Silvia Hofer
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Revue Medicale Suisse|March 5, 2016
[Why do we need molecular medicine in oncology]Silvia Hofer
Praxis|April 13, 2017
Silvia Hofer
Targeted Oncology|September 10, 2010
Targeted therapies on the horizon for malignant gliomaSilvia Hofer, Roger Stupp
Journal of Neuro-Oncology|September 30, 2006
Gefitinib concentrations in human glioblastoma tissueSilvia Hofer, Karl Frei
European Journal of Cancer (Oxford, England : 1990)|October 2, 2018
Letter comments on EJC published article: Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2-positive breast carcinomatous meningitisSilvia Hofer, Stefan Aebi
European Journal of Pharmacology|April 3, 2013
Treatment of breast cancer brain metastasesSilvia Hofer, Bernhard C Pestalozzi
Targeted Oncology|September 3, 2010
Molecular markers in gliomas: impact for the clinicianSilvia Hofer, Andrew B Lassman
Praxis|December 13, 2017
Désirée Gassmann, Sandra Schmid, Silvia Hofer
Acta Oncologica (Stockholm, Sweden)|December 25, 2008
Evolution of glioblastomaSilvia Hofer, Spyros Kollias, Michael Weller
BMC Medical Informatics and Decision Making|July 23, 2013
Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluationDominik Péus, Nicolas Newcomb, Silvia Hofer
Pageof 7